Bristol-Myers Squibb Overview

  • Founded
  • 1887
Founded
  • Status
  • Public
  • Employees
  • 30,250
Employees
  • Stock Symbol
  • BMY
Stock Symbol
  • Investments
  • 70
  • Share Price
  • $65.46
  • (As of Monday Closing)

Bristol-Myers Squibb General Information

Description

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, oncology, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is leading in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.

Contact Information

Website
www.bms.com
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Biotechnology
Stock Exchange
NYS
Primary Office
  • 430 East 29th Street
  • 14th Floor
  • New York, NY 10016
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Bristol-Myers Squibb Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$65.46 $64.88 $54.07 - $67.16 $145B 2.23B 11.8M -$2.76

Bristol-Myers Squibb Financials Summary

In Thousands,
USD
TTM 31-Mar-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 176,310,871 164,770,387 143,062,835 85,428,692
Revenue 42,810,000 42,518,000 26,145,000 22,561,000
EBITDA 7,945,000 (4,855,100) 6,186,300 6,854,000
Net Income (6,219,000) (9,015,000) 3,439,000 4,920,000
Total Assets 112,435,000 118,481,000 129,944,000 34,986,000
Total Debt 47,269,000 51,673,000 47,538,000 7,349,000
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Bristol-Myers Squibb Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Bristol-Myers Squibb‘s full profile, request access.

Request a free trial

Bristol-Myers Squibb Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, oncol
Drug Discovery
New York, NY
30,250 As of 2020
00000
000000000 00000

00000 &

dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliq
000000000000000
Kenilworth, NJ
00000 As of 0000
00000000

00000

qua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commod
0000000000000
Thousand Oaks, CA
00000 As of 0000
00.000
000000000000 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Bristol-Myers Squibb Competitors (42)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Merck & Co. Corporation Kenilworth, NJ 00000 00000000
00000 Formerly PE-Backed Thousand Oaks, CA 00000 00.000 000000000000 00.000
000000 Formerly VC-backed Cambridge, MA 0000 000.00 00000000000 000.00
00000000 000000000 Formerly VC-backed Westlake Village, CA 000 00000 000000 - 000 00000
000000 00000000000 Corporation Plymouth Meeting, PA 000 000.00 00000000 000.00
You’re viewing 5 of 42 competitors. Get the full list »

Bristol-Myers Squibb Executive Team (53)

Name Title Board Seat Contact Info
Giovanni Caforio MD Chairman of the Board and Chief Executive Officer
Louis Schmukler Executive Vice President and President, Global Product Development & Supply
Payal Roy President- Oncology / Immuno-Oncology
David Elkins Executive Vice President and Chief Financial Officer
Karen Santiago Chief Accounting Officer, Accounting & Controller, Finance
You’re viewing 5 of 53 executive team members. Get the full list »

Bristol-Myers Squibb Board Members (19)

Name Representing Role Since
000000 0000 Self Board Member 000 0000
000000 0000000 Self Board Member 000 0000
000000 000000 00 Self Board Member 000 0000
00000000 0000000 00 Bristol-Myers Squibb Chairman of the Board and Chief Executive Officer 000 0000
00000 000000 00 Self Board Member 000 0000
You’re viewing 5 of 19 board members. Get the full list »

Bristol-Myers Squibb Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Bristol-Myers Squibb Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Bristol-Myers Squibb‘s full profile, request access.

Request a free trial

Bristol-Myers Squibb Investments & Acquisitions (70)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000000 27-Apr-2021 00000 00000 00 00000 Drug Discovery
00000 00000000 18-Mar-2021 00000 00000 00 0000 Drug Delivery
0000000000 03-Mar-2021 00000 00000 00 00000 Drug Discovery
0000000 0000000000 02-Mar-2021 00000 00000 00 0000 Drug Discovery
Orna Therapeutics 24-Feb-2021 Early Stage VC 0000 Biotechnology
You’re viewing 5 of 70 investments and acquisitions. Get the full list »

Bristol-Myers Squibb Subsidiaries (8)

Company Name Industry Location Founded
IFM Therapeutics Drug Discovery Boston, MA 2015
000000000 Drug Discovery Brisbane, CA 0000
0000000 Biotechnology Austin, TX 0000
0000000 Drug Discovery Copenhagen North, Denmark 0000
0000000 Biotechnology Summit, NJ 0000
You’re viewing 5 of 8 subsidiaries. Get the full list »

Bristol-Myers Squibb Exits (22)

Company Name Exit Date Exit Type Exit Size Status Buyers
00000 00000000 05-Jan-2021 00000 00000 00 00000 Completed
  • 12 buyers
000000 00000000000 29-May-2020 000000000 0000 Completed
  • 2 buyers
00000 00000000 18-Jan-2019 000000000 0000 Completed
  • 2 buyers
000 000 19-Jul-2018 00000 00000 00 000.00 Completed
  • 3 buyers
Taris Biomedical (US) 21-Dec-2017 Later Stage VC 0000 Completed
  • 6 buyers
You’re viewing 5 of 22 exits. Get the full list »